MusthInsider

Latest On LogicBio Therapeutics, Inc (LOGC):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2022-11-16 14:25 EST	News	AstraZeneca's Alexion completes acquisition of genomic medicine company LogicBio	N/A
2022-11-14 11:21 EST	News	LogicBio GAAP EPS of -$0.18 beats by $0.02, revenue of $2.72M beats by $0.72M	N/A
2022-10-03 13:25 EST	News	LogicBio jumps 648% on buyout deal with AstraZeneca unit Alexion	N/A
2022-08-15 18:03 EST	News	LogicBio GAAP EPS of -$0.15, revenue of $3.2M	N/A
2022-05-24 22:23 EST	News	LogicBio Therapeutics (LOGC) Investor Presentation - Slideshow	N/A
2022-05-16 14:46 EST	News	LogicBio GAAP EPS of -$0.20, revenue of $2.81M	N/A
2022-05-09 12:48 EST	News	LogicBio surges as FDA lifts clinical hold on lead asset	N/A
2022-03-05 01:32 EST	News	LogicBio GAAP EPS of -$1.24 beats by $0.08, revenue of $5.41M beats by $0.56M	N/A
2022-02-04 06:43 EST	News	LogicBio downgraded at William Blair citing lack of clarity on catalysts after clinical hold	N/A
2022-02-02 21:14 EST	News	LogicBio falls on FDA clinical hold on gene therapy program for metabolic disease	N/A
2021-11-22 05:25 EST	News	Warning: LOGC is at high risk of performing badly	N/A
2021-08-09 10:42 EST	News	LogicBio EPS misses by $0.14, misses on revenue	N/A
2021-07-21 14:47 EST	News	LogicBio trades higher as gene editing stocks rally	N/A
2021-04-27 20:08 EST	News	LogicBio announces agreements with CANbridge Pharma and Daiichi Sankyo	N/A
2021-03-17 13:05 EST	Financials	Company financials have been released.	Neutral
2021-03-17 03:33 EST	News	LogicBio EPS misses by $0.03, beats on revenue	N/A
2021-03-16 21:18 EST	Earnings Estimate	An EPS average of -$1.44 is estimated for the 2022 year.	Sell
2021-03-16 21:18 EST	Earnings Estimate	An EPS average of -$0.28 is estimated for the quarter ending on June 30, 2021.	Sell
2021-03-05 15:54 EST	Analyst Rating	The Analyst Target Price has decreased from $21.33 to $20.25.	Neutral
2021-01-07 13:46 EST	News	LogicBio extends collaboration with Children's Medical Research Institute	N/A
2021-01-06 16:04 EST	Financials	Company financials have been released.	Neutral
2020-12-22 22:33 EST	News	LogicBio Therapeutics names new CFO	N/A
2020-11-26 20:42 EST	Financials	Company financials have been released.	Neutral
2020-11-17 13:08 EST	News	Looking In On LogicBio	N/A
2020-11-12 12:15 EST	Financials	Company financials have been released.	Neutral
2020-11-11 12:21 EST	Financials	Company financials have been released.	Neutral
2020-11-11 04:21 EST	Analyst Rating	The Analyst Target Price has decreased from $22 to $21.33.	Neutral
2020-11-10 04:21 EST	Earnings Estimate	An EPS average of -$0.41 is estimated for the quarter ending on March 31, 2021.	Sell
2020-11-09 13:15 EST	News	LogicBio reports Q3 results	N/A
2020-11-07 16:22 EST	Financials	Company financials have been released.	Neutral
2020-11-05 08:43 EST	News	LogicBio's LB-001 Fast Track'd for methylmalonic acidemia; shares +10%	N/A
2020-11-05 08:43 EST	News	LogicBio's LB-001 fast track'd in U.S. for an inherited metabolic disorder	N/A
2020-11-04 05:37 EST	News	LogicBio Therapeutics announces executive leadership changes	N/A
2020-10-05 17:57 EST	Insider Trade	Erez Chimovits has indirectly acquired of 296,296 shares.	Buy
2020-10-05 17:57 EST	Insider Trade	Erez Chimovits has indirectly acquired of 639,212 shares.	Buy
2020-10-05 17:57 EST	Insider Trade	Erez Chimovits has indirectly acquired of 545,974 shares.	Buy
2020-10-05 17:57 EST	Insider Trade	ORBIMED ADVISORS LLC has indirectly acquired of 296,296 shares.	Buy
2020-10-05 17:57 EST	Insider Trade	ORBIMED ADVISORS LLC has indirectly acquired of 639,212 shares.	Buy
2020-10-05 17:57 EST	Insider Trade	ORBIMED ADVISORS LLC has indirectly acquired of 545,974 shares.	Buy
2020-10-05 17:15 EST	Insider Trade	Bioscience plc Arix has indirectly disposed of 273,584 shares.	Sell
2020-10-05 17:15 EST	Insider Trade	Bioscience plc Arix has indirectly disposed of 174,219 shares.	Sell
2020-10-05 17:15 EST	Insider Trade	Bioscience plc Arix has indirectly disposed of 38,514 shares.	Sell
2020-10-01 17:12 EST	News	LogicBio readies equity offering	N/A
2020-10-01 17:10 EST	News	LogicBio Therapeutics -30% on pricing of equity offering	N/A
2020-09-26 13:17 EST	Financials	Company financials have been released.	Neutral
2020-09-17 05:24 EST	Financials	Company financials have been released.	Neutral
2020-08-14 09:21 EST	Financials	Company financials have been released.	Neutral
2020-08-12 05:12 EST	Financials	Company financials have been released.	Neutral
2020-08-11 21:15 EST	Analyst Rating	The Analyst Target Price has increased from $20.33 to $22.	Buy
2020-08-11 05:05 EST	Financials	Company financials have been released.	Neutral

About LogicBio Therapeutics, Inc (LOGC):

LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. The company's lead product candidate is LB-001 for the treatment of Methylmalonic Acidemia, a life-threatening disease that presents at birth. It has a partnership with Children's Medical Research Institute to develop new viral vectors; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop new genome editing candidate LB-301 for the treatment of crigler-najjar syndrome. The company was founded in 2014 and is headquartered in Lexington, Massachusetts.

See Advanced Chart

General

Name LogicBio Therapeutics, Inc
Symbol LOGC
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Fiscal Year EndDecember
IPO Date2018-10-19
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLhttp://www.logicbio.com

Valuation

Price/Sales (Trailing 12 Mt.) 61.91
Price/Book (Most Recent Quarter) 4.4
Enterprise Value Revenue 62.53

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$1.16
Next Year EPS Estimate -$1.12
Next Quarter EPS Estimate -$0.35
Operating Margin -912%
Return on Assets -29%
Return on Equity -63%
Revenue 3.45 million
Earnings Per Share -$1.55
Revenue Per Share $0.14
Gross Profit 3.45 million
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 254.61 million
EBITDA -30350000
PE Ratio -0.64
Analyst Target Price $20.25
Book Value Per Share $1.93

Share Statistics

Shares Outstanding 31.79 million
Shares Float 17.29 million
% Held by Insiders 1369%
% Held by Institutions 53%
Shares Short 827300
Shares Short Prior Month 677650
Short Ratio 6.35
Short % of Float 4%
Short % of Shares Outstanding 3%

Technicals

Beta 1.31
52 Week High $10
52 Week Low $4.02
50 Day Moving Average 8.36
200 Day Moving Average 7.32

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

LogicBio Therapeutics, Inc (LOGC) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

LogicBio Therapeutics, Inc (LOGC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-16	$N/A	-$0.22	-$0.32	31.25%
2020-09-30	2020-11-09	$N/A	-$0.34	-$0.41	17.58%
2020-06-30	2020-08-10	$N/A	-$0.35	-$0.48	27.08%
2020-03-31	2020-05-11	$1.02 million	-$0.41	-$0.48	14.23%
2019-12-31	2020-03-16	$N/A	-$0.51	-$0.49	-5.15%
2019-09-30	2019-11-12	$N/A	-$0.48	-$0.47	-3.23%
2019-06-30	2019-08-13	$N/A	-$0.45	-$0.40	-12.5%
2019-03-31	2019-05-14	$N/A	-$0.34	-$0.29	-18.26%
2018-12-31	2018-12-31	$N/A	-$0.41	-$0.39	-5.13%
2018-09-30	2018-12-03	$N/A	-$4.03	-$3.87	-4.27%

LogicBio Therapeutics, Inc (LOGC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

LogicBio Therapeutics, Inc (LOGC) Chart:

LogicBio Therapeutics, Inc (LOGC) News:

Below you will find a list of latest news for LogicBio Therapeutics, Inc (LOGC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

LogicBio Therapeutics, Inc (LOGC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2025-06-20	1	0	CALL	0	0	598.44	TRUE	0	0
2025-06-20	2	0	CALL	0	0	395.2	TRUE	0	0
2025-06-20	3	0	CALL	0	0	286.48	TRUE	0	0
2025-06-20	4	0	CALL	0	0	294.6	TRUE	0	0
2025-06-20	5	0	CALL	0	0	164.6	TRUE	0	0
2025-06-20	6	0	CALL	0	0	279.84	TRUE	0	0
2025-06-20	7	1.19	CALL	0	28	75.83	TRUE	0	0
2025-06-20	8	0.43	CALL	4	318	40.82	TRUE	-0.11	-0.2
2025-06-20	9	0.1	CALL	0	93	45.48	FALSE	0	0
2025-06-20	10	0.05	CALL	0	4	73.85	FALSE	0	0
2025-06-20	11	0	CALL	0	0	242.94	FALSE	0	0
2025-06-20	12	0	CALL	0	0	234.56	FALSE	0	0
2025-06-20	13	0	CALL	0	0	242.06	FALSE	0	0
2025-06-20	1	0	PUT	0	0	0	FALSE	0	0
2025-06-20	2	0	PUT	0	0	975.48	FALSE	0	0
2025-06-20	3	0	PUT	0	0	684.33	FALSE	0	0
2025-06-20	4	0	PUT	0	0	518.76	FALSE	0	0
2025-06-20	5	0.05	PUT	0	1	117.9	FALSE	0	0
2025-06-20	6	0	PUT	0	22	79.92	FALSE	0	0
2025-06-20	7	0	PUT	0	3	79.25	FALSE	0	0
2025-06-20	8	0.15	PUT	0	587	170.59	FALSE	0	0
2025-06-20	9	0	PUT	0	0	149.64	TRUE	0	0
2025-06-20	10	0	PUT	0	0	164.22	TRUE	0	0
2025-06-20	11	0	PUT	0	0	245.94	TRUE	0	0
2025-06-20	12	0	PUT	0	0	275.92	TRUE	0	0
2025-06-20	13	0	PUT	0	0	299.07	TRUE	0	0
2025-07-18	1	0	CALL	0	0	326.58	TRUE	0	0
2025-07-18	2	0	CALL	0	0	213.01	TRUE	0	0
2025-07-18	3	0	CALL	0	0	251.13	TRUE	0	0
2025-07-18	4	0	CALL	0	0	187.91	TRUE	0	0
2025-07-18	5	0	CALL	0	1547	148.77	TRUE	0	0
2025-07-18	6	0	CALL	0	413	64.67	TRUE	0	0
2025-07-18	7	1.3	CALL	0	1810	59.58	TRUE	0	0
2025-07-18	8	0.65	CALL	150	3830	53.1	TRUE	0.65	0
2025-07-18	9	0.35	CALL	0	157	98.35	FALSE	0	0
2025-07-18	10	0.2	CALL	0	100	142.34	FALSE	0	0
2025-07-18	11	0	CALL	0	2	125.12	FALSE	0	0
2025-07-18	12	0	CALL	0	0	141.49	FALSE	0	0
2025-07-18	13	0	CALL	0	0	155.67	FALSE	0	0
2025-07-18	14	0	CALL	0	0	168.2	FALSE	0	0
2025-07-18	15	0	CALL	0	9	130.18	FALSE	0	0
2025-07-18	16	0	CALL	0	0	189.59	FALSE	0	0
2025-07-18	17	0	CALL	0	0	198.88	FALSE	0	0
2025-07-18	18	0	CALL	0	0	207.42	FALSE	0	0
2025-07-18	1	0	PUT	0	0	0	FALSE	0	0
2025-07-18	2	0	PUT	0	0	631.25	FALSE	0	0
2025-07-18	3	0	PUT	0	0	442.89	FALSE	0	0
2025-07-18	4	0	PUT	0	0	335.89	FALSE	0	0
2025-07-18	5	0	PUT	0	0	203.7	FALSE	0	0
2025-07-18	6	0.15	PUT	0	194	77.26	FALSE	0	0
2025-07-18	7	0	PUT	0	448	48.33	FALSE	0	0
2025-07-18	8	0.6	PUT	0	552	50.29	FALSE	0	0
2025-07-18	9	0	PUT	0	0	74.57	TRUE	0	0
2025-07-18	10	0	PUT	0	0	142.3	TRUE	0	0
2025-07-18	11	0	PUT	0	0	120.66	TRUE	0	0
2025-07-18	12	0	PUT	0	0	96.64	TRUE	0	0
2025-07-18	13	0	PUT	0	0	195.51	TRUE	0	0
2025-07-18	14	0	PUT	0	0	208.96	TRUE	0	0
2025-07-18	15	0	PUT	0	0	221.05	TRUE	0	0
2025-07-18	16	0	PUT	0	0	232.03	TRUE	0	0
2025-07-18	17	0	PUT	0	0	242.07	TRUE	0	0
2025-07-18	18	0	PUT	0	0	246.73	TRUE	0	0
2025-10-17	1	0	CALL	0	0	183.29	TRUE	0	0
2025-10-17	2	0	CALL	0	0	110.33	TRUE	0	0
2025-10-17	3	0	CALL	0	0	143.36	TRUE	0	0
2025-10-17	4	0	CALL	0	0	159.02	TRUE	0	0
2025-10-17	5	0	CALL	0	0	129.5	TRUE	0	0
2025-10-17	6	0	CALL	0	102	43.8	TRUE	0	0
2025-10-17	7	1.9	CALL	0	85	60.93	TRUE	0	0
2025-10-17	8	0	CALL	0	68	96.45	TRUE	0	0
2025-10-17	9	0.95	CALL	0	81	54.91	FALSE	0	0
2025-10-17	10	0.71	CALL	0	3944	56.81	FALSE	0	0
2025-10-17	11	0	CALL	0	1	104.26	FALSE	0	0
2025-10-17	12	0	CALL	0	4	108.2	FALSE	0	0
2025-10-17	13	0	CALL	0	112	78.55	FALSE	0	0
2025-10-17	14	0	CALL	0	2	122.25	FALSE	0	0
2025-10-17	15	0.19	CALL	0	300	68.81	FALSE	0	0
2025-10-17	16	0	CALL	0	0	134.19	FALSE	0	0
2025-10-17	17	0	CALL	0	0	117.41	FALSE	0	0
2025-10-17	18	0	CALL	0	2044	128.43	FALSE	0	0
2025-10-17	1	0	PUT	0	0	0	FALSE	0	0
2025-10-17	2	0	PUT	0	0	373.96	FALSE	0	0
2025-10-17	3	0	PUT	0	0	221.14	FALSE	0	0
2025-10-17	4	0	PUT	0	0	160.4	FALSE	0	0
2025-10-17	5	0	PUT	0	300	148.61	FALSE	0	0
2025-10-17	6	0	PUT	0	1570	88.16	FALSE	0	0
2025-10-17	7	0.6	PUT	0	457	67.58	FALSE	0	0
2025-10-17	8	1	PUT	0	112	106.8	FALSE	0	0
2025-10-17	9	1.65	PUT	0	51	61.35	TRUE	0	0
2025-10-17	10	0	PUT	0	2	80.43	TRUE	0	0
2025-10-17	11	0	PUT	0	9	60.41	TRUE	0	0
2025-10-17	12	0	PUT	0	0	61.66	TRUE	0	0
2025-10-17	13	0	PUT	0	0	119.25	TRUE	0	0
2025-10-17	14	0	PUT	0	0	111.59	TRUE	0	0
2025-10-17	15	0	PUT	0	0	135.03	TRUE	0	0
2025-10-17	16	0	PUT	0	0	104.43	TRUE	0	0
2025-10-17	17	0	PUT	0	0	148.11	TRUE	0	0
2025-10-17	18	0	PUT	0	0	95.95	TRUE	0	0
2026-01-16	1	0	CALL	0	3	0	TRUE	0	0
2026-01-16	2	0	CALL	0	2	0	TRUE	0	0
2026-01-16	3	0	CALL	0	152	183.98	TRUE	0	0
2026-01-16	4	0	CALL	0	219	133.96	TRUE	0	0
2026-01-16	5	0	CALL	0	1724	88.24	TRUE	0	0
2026-01-16	6	0	CALL	0	0	65.04	TRUE	0	0
2026-01-16	7	2.2	CALL	3587	12092	69.97	TRUE	-0.05	-0.02
2026-01-16	8	1.65	CALL	0	336	72.48	TRUE	0	0
2026-01-16	9	1.2	CALL	40	0	54.88	FALSE	1.2	0
2026-01-16	10	1.04	CALL	3900	1728	60.46	FALSE	1.04	0
2026-01-16	11	0	CALL	0	0	82.92	FALSE	0	0
2026-01-16	12	0	CALL	0	111	51.58	FALSE	0	0
2026-01-16	13	0	CALL	0	0	92.06	FALSE	0	0
2026-01-16	14	0	CALL	0	0	96.18	FALSE	0	0
2026-01-16	15	0.2	CALL	0	4333	103.65	FALSE	0	0
2026-01-16	16	0	CALL	0	0	104.53	FALSE	0	0
2026-01-16	17	0	CALL	0	2	107.99	FALSE	0	0
2026-01-16	1	0	PUT	0	41	0	FALSE	0	0
2026-01-16	2	0	PUT	0	72	293.03	FALSE	0	0
2026-01-16	3	0	PUT	0	45	205.76	FALSE	0	0
2026-01-16	4	0	PUT	0	914	156.47	FALSE	0	0
2026-01-16	5	0	PUT	0	2029	68.13	FALSE	0	0
2026-01-16	6	0	PUT	0	50	107.9	FALSE	0	0
2026-01-16	7	0	PUT	0	28	97.83	FALSE	0	0
2026-01-16	8	1.55	PUT	0	101	37.73	FALSE	0	0
2026-01-16	9	0	PUT	0	0	72.85	TRUE	0	0
2026-01-16	10	0	PUT	0	0	66.68	TRUE	0	0
2026-01-16	11	0	PUT	0	0	63.68	TRUE	0	0
2026-01-16	12	0	PUT	0	0	59.89	TRUE	0	0
2026-01-16	13	0	PUT	0	0	60.58	TRUE	0	0
2026-01-16	14	0	PUT	0	0	60.63	TRUE	0	0
2026-01-16	15	0	PUT	0	0	62.32	TRUE	0	0
2026-01-16	16	0	PUT	0	0	112.07	TRUE	0	0
2026-01-16	17	0	PUT	0	0	119.22	TRUE	0	0

Latest LOGC Trades:

Date	Shares	Price
Jun 13, 2022 7:47 PM EST	200	$0.4539
Jun 13, 2022 7:50 PM EST	100	$0.4499
Jun 13, 2022 7:50 PM EST	200	$0.4499
Jun 13, 2022 7:50 PM EST	100	$0.4499
Jun 13, 2022 7:50 PM EST	100	$0.4477

LogicBio Therapeutics, Inc (LOGC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-06-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520178928/0001193125-20-178928-index.htm
2019-11-21	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1664106/000000000019015732/0000000000-19-015732-index.htm
2020-05-28	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1664106/000000000020004765/0000000000-20-004765-index.htm
2020-06-08	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1664106/000000000020005085/0000000000-20-005085-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318026987/0000899243-18-026987-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318026988/0000899243-18-026988-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318026992/0000899243-18-026992-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318026993/0000899243-18-026993-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318026994/0000899243-18-026994-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318026998/0000899243-18-026998-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318026999/0000899243-18-026999-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027001/0000899243-18-027001-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027002/0000899243-18-027002-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027005/0000899243-18-027005-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027007/0000899243-18-027007-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027010/0000899243-18-027010-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027011/0000899243-18-027011-index.htm
2018-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027012/0000899243-18-027012-index.htm
2018-10-19	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027096/0000899243-18-027096-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027210/0000899243-18-027210-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027211/0000899243-18-027211-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027212/0000899243-18-027212-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027213/0000899243-18-027213-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027217/0000899243-18-027217-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027218/0000899243-18-027218-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027219/0000899243-18-027219-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027222/0000899243-18-027222-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027225/0000899243-18-027225-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027226/0000899243-18-027226-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027227/0000899243-18-027227-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027229/0000899243-18-027229-index.htm
2018-10-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027231/0000899243-18-027231-index.htm
2018-10-24	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027375/0000899243-18-027375-index.htm
2018-10-24	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027378/0000899243-18-027378-index.htm
2018-10-24	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027379/0000899243-18-027379-index.htm
2018-10-24	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027380/0000899243-18-027380-index.htm
2018-10-24	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027381/0000899243-18-027381-index.htm
2018-10-25	3/A	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027415/0000899243-18-027415-index.htm
2018-10-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027475/0000899243-18-027475-index.htm
2018-10-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027477/0000899243-18-027477-index.htm
2018-10-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027478/0000899243-18-027478-index.htm
2018-10-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2018-10-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027481/0000899243-18-027481-index.htm
2018-10-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027509/0000899243-18-027509-index.htm
2019-02-22	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924319004572/0000899243-19-004572-index.htm
2019-02-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924319004574/0000899243-19-004574-index.htm
2019-08-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924319022576/0000899243-19-022576-index.htm
2020-10-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2019-05-17	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1664106/000090266419002407/0000902664-19-002407-index.htm
2020-02-12	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1664106/000090266420000940/0000902664-20-000940-index.htm
2018-11-01	SC 13D	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1664106/000094787118000868/0000947871-18-000868-index.htm
2020-10-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2020-10-06	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1664106/000094787120000780/0000947871-20-000780-index.htm
2018-10-09	S-1/A	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1664106/000119312518295666/0001193125-18-295666-index.htm
2018-10-11	S-1/A	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1664106/000119312518297645/0001193125-18-297645-index.htm
2018-10-16	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1664106/000119312518300264/0001193125-18-300264-index.htm
2018-10-16	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1664106/000119312518300269/0001193125-18-300269-index.htm
2018-10-17	S-1/A	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1664106/000119312518301103/0001193125-18-301103-index.htm
2018-10-17	8-A12B	Registration of securities [Section 12(b)]	https://www.sec.gov/Archives/edgar/data/1664106/000119312518301114/0001193125-18-301114-index.htm
2018-10-19	POS EX	Post-effective amendment adding exhibits to registration statement [Rule 462(d)]	https://www.sec.gov/Archives/edgar/data/1664106/000119312518302176/0001193125-18-302176-index.htm
2018-10-22	424B4	Prospectus [Rule 424(b)(4)]	https://www.sec.gov/Archives/edgar/data/1664106/000119312518303289/0001193125-18-303289-index.htm
2018-10-29	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312518310599/0001193125-18-310599-index.htm
2018-11-02	SC 13D	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1664106/000119312518317070/0001193125-18-317070-index.htm
2018-12-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312518340421/0001193125-18-340421-index.htm
2018-12-03	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1664106/000119312518341169/0001193125-18-341169-index.htm
2018-12-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312518354565/0001193125-18-354565-index.htm
2019-02-12	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1664106/000119312519036007/0001193125-19-036007-index.htm
2019-02-12	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1664106/000119312519036039/0001193125-19-036039-index.htm
2019-02-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519057916/0001193125-19-057916-index.htm
2019-04-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519093656/0001193125-19-093656-index.htm
2019-04-01	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1664106/000119312519094593/0001193125-19-094593-index.htm
2019-04-02	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1664106/000119312519095708/0001193125-19-095708-index.htm
2019-04-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519105205/0001193125-19-105205-index.htm
2019-04-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519110925/0001193125-19-110925-index.htm
2019-04-29	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1664106/000119312519125202/0001193125-19-125202-index.htm
2019-04-29	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1664106/000119312519125235/0001193125-19-125235-index.htm
2019-05-14	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519146010/0001193125-19-146010-index.htm
2019-05-14	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1664106/000119312519146603/0001193125-19-146603-index.htm
2019-06-24	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519180202/0001193125-19-180202-index.htm
2019-06-27	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519184362/0001193125-19-184362-index.htm
2019-07-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519188256/0001193125-19-188256-index.htm
2019-08-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519219514/0001193125-19-219514-index.htm
2019-08-13	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1664106/000119312519219972/0001193125-19-219972-index.htm
2019-11-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519288366/0001193125-19-288366-index.htm
2019-11-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312519289315/0001193125-19-289315-index.htm
2019-11-15	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1664106/000119312519293465/0001193125-19-293465-index.htm
2019-11-21	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1664106/000119312519297651/0001193125-19-297651-index.htm
2020-01-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520005091/0001193125-20-005091-index.htm
2020-02-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520029995/0001193125-20-029995-index.htm
2020-03-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520074884/0001193125-20-074884-index.htm
2020-03-17	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1664106/000119312520075995/0001193125-20-075995-index.htm
2020-03-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520080815/0001193125-20-080815-index.htm
2020-04-29	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1664106/000119312520124363/0001193125-20-124363-index.htm
2020-04-29	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1664106/000119312520124383/0001193125-20-124383-index.htm
2020-05-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520139024/0001193125-20-139024-index.htm
2020-06-05	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1664106/000119312520161349/0001193125-20-161349-index.htm
2020-06-05	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1664106/000119312520162213/0001193125-20-162213-index.htm
2020-06-05	10-K/A	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1664106/000119312520162226/0001193125-20-162226-index.htm
2020-06-05	10-Q/A	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1664106/000119312520162248/0001193125-20-162248-index.htm
2020-06-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520171447/0001193125-20-171447-index.htm
2020-06-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520178928/0001193125-20-178928-index.htm
2020-08-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520214074/0001193125-20-214074-index.htm
2020-09-29	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1664106/000119312520257792/0001193125-20-257792-index.htm
2020-09-30	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1664106/000119312520259681/0001193125-20-259681-index.htm
2020-09-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520259688/0001193125-20-259688-index.htm
2020-10-02	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1664106/000119312520262477/0001193125-20-262477-index.htm
2020-10-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520263197/0001193125-20-263197-index.htm
2020-11-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1664106/000119312520284838/0001193125-20-284838-index.htm
2019-11-20	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919119057546/0001209191-19-057546-index.htm
2019-12-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919119060530/0001209191-19-060530-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919119061660/0001209191-19-061660-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919119061662/0001209191-19-061662-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919119061663/0001209191-19-061663-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919119061664/0001209191-19-061664-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919119061665/0001209191-19-061665-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919119061666/0001209191-19-061666-index.htm
2019-12-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919119061671/0001209191-19-061671-index.htm
2020-02-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120009447/0001209191-20-009447-index.htm
2020-02-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120009448/0001209191-20-009448-index.htm
2020-02-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120009449/0001209191-20-009449-index.htm
2020-02-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120009450/0001209191-20-009450-index.htm
2020-03-19	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120020340/0001209191-20-020340-index.htm
2020-03-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120020355/0001209191-20-020355-index.htm
2020-04-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120024991/0001209191-20-024991-index.htm
2020-04-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120024992/0001209191-20-024992-index.htm
2020-04-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120024993/0001209191-20-024993-index.htm
2020-06-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120038659/0001209191-20-038659-index.htm
2020-06-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120038661/0001209191-20-038661-index.htm
2020-06-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120038662/0001209191-20-038662-index.htm
2020-06-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120038664/0001209191-20-038664-index.htm
2020-06-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120038665/0001209191-20-038665-index.htm
2020-06-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120038667/0001209191-20-038667-index.htm
2020-06-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1664106/000120919120038668/0001209191-20-038668-index.htm
2020-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1664106/000121390020003725/0001213900-20-003725-index.htm
2020-02-21	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1664106/000121390020004495/0001213900-20-004495-index.htm
2018-10-18	CERT	Certification	https://www.sec.gov/Archives/edgar/data/1664106/000135445718000419/0001354457-18-000419-index.htm
2019-11-12	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1664106/000156459019042912/0001564590-19-042912-index.htm
2020-03-16	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1664106/000156459020011170/0001564590-20-011170-index.htm
2020-05-11	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1664106/000156459020024240/0001564590-20-024240-index.htm
2020-08-10	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1664106/000156459020038622/0001564590-20-038622-index.htm
2018-10-18	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1664106/999999999518002661/9999999995-18-002661-index.htm
2019-11-25	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1664106/999999999519002659/9999999995-19-002659-index.htm
2018-10-18	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1664106/999999999718008680/9999999997-18-008680-index.htm
2019-04-26	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1664106/999999999719003401/9999999997-19-003401-index.htm

LogicBio Therapeutics, Inc (LOGC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of LogicBio Therapeutics, Inc (LOGC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1369%
Institutional Ownership: 5300%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2018-10-23	Tomer Kariv	Director	Buy	207,151.00	10.00	2,071,510.00	1,574,564.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2018-10-23	Tomer Kariv	Director	Buy	112,000.00	10.00	1,120,000.00	1,686,564.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2018-10-23	Sofia Ioannidou	Director	Buy	420,000.00	10.00	4,200,000.00	1,787,413.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027478/0000899243-18-027478-index.htm
2018-10-23	Tomer Kariv	Director	Buy	100,849.00	10.00	1,008,490.00	1,787,413.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2020-09-28	Bioscience plc Arix	10% Share Holder	Sell	273,584.00	7.54	2,061,865.82	2,381,436.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2020-09-25	Bioscience plc Arix	10% Share Holder	Sell	174,219.00	7.08	1,232,947.86	2,655,020.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2020-09-24	Bioscience plc Arix	10% Share Holder	Sell	38,514.00	7.63	293,823.31	2,829,239.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2020-10-01	Erez Chimovits	Director	Buy	296,296.00	6.00	1,777,776.00	296,296.00	https://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-01	ORBIMED ADVISORS LLC	Director	Buy	296,296.00	6.00	1,777,776.00	296,296.00	https://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2018-10-23	Bioscience plc Arix	10% Share Holder	Buy	700,000.00	10.00	7,000,000.00	2,979,023.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027509/0000899243-18-027509-index.htm
2018-10-23	Daniel P O'Connell	Director	Buy	700,000.00	10.00	7,000,000.00	2,979,023.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027477/0000899243-18-027477-index.htm
2018-10-23	Erez Chimovits	Director	Buy	490,000.00	10.00	4,900,000.00	3,487,760.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027475/0000899243-18-027475-index.htm
2020-10-01	Erez Chimovits	Director	Buy	545,974.00	6.00	3,275,844.00	3,524,997.00	https://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-01	ORBIMED ADVISORS LLC	Director	Buy	545,974.00	6.00	3,275,844.00	3,524,997.00	https://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2020-10-01	Erez Chimovits	Director	Buy	639,212.00	6.00	3,835,272.00	4,126,972.00	https://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-01	ORBIMED ADVISORS LLC	Director	Buy	639,212.00	6.00	3,835,272.00	4,126,972.00	https://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2018-10-23	ORBIMED ADVISORS LLC	Director	Buy	490,000.00	10.00	4,900,000.00	5,766,783.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027481/0000899243-18-027481-index.htm
2018-10-23	ORBIMED ADVISORS LLC	Director	Buy	700,000.00	10.00	7,000,000.00	6,466,783.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924318027481/0000899243-18-027481-index.htm
2019-08-27	Thomas Wilton	Chief Business Officer	Buy	75,000.00	0.73	54,750.00	75,000.00	https://www.sec.gov/Archives/edgar/data/1664106/000089924319022576/0000899243-19-022576-index.htm

LogicBio Therapeutics, Inc

(NASDAQ:LOGC)